Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
XP Maxamaid Concentrate powder
090401000BBCDA0
|
Proprietary compound foods for special diets | Other food for special diet preparations | Nutrition and Blood | No data available |
|
XPHEN TYR Analog powder
090401000BBEEA0
|
Proprietary compound foods for special diets | Other food for special diet preparations | Nutrition and Blood | No data available |
|
XPTM Analog powder
090401000BBICA0
|
Proprietary compound foods for special diets | Other food for special diet preparations | Nutrition and Blood | No data available |
|
XPTM Tyrosidon powder
090401000BBENA0
|
Proprietary compound foods for special diets | Other food for special diet preparations | Nutrition and Blood | No data available |
|
Yakult Light yoghurt drink
090900000BBKBA0
|
Proprietary compound preparation BNF 0909000 | Other food preparations | Nutrition and Blood | No data available |
|
Yakult yoghurt drink
0913531A0BCAAAB
|
Yakult liquid OTC probiotic | Liquid OTC probiotic (0913531) | Nutrition and Blood | No data available |
|
Yargesa 100mg capsules
0908010ACBCAAAA
|
Yargesa | Miglustat | Nutrition and Blood | No data available |
|
Yariba tablets
091200000BFLIA0
|
Proprietary compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Yeast plasmolysate 4ml/5ml oral solution
091200000AAGDGD
|
Generic compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
YPV Vitamin D3 1,000unit tablets
0906040G0EHAABG
|
YPV Vitamin D3 | Colecalciferol | Nutrition and Blood | No data available |
|
YPV Vitamin D3 20,000unit tablets
0906040G0EHABCR
|
YPV Vitamin D3 | Colecalciferol | Nutrition and Blood | No data available |
|
YPV Vitamin D3 4,000unit tablets
0906040G0EHACEE
|
YPV Vitamin D3 | Colecalciferol | Nutrition and Blood | No data available |
|
YPV Vitamin D3 400unit tablets
0906040G0EHADEL
|
YPV Vitamin D3 | Colecalciferol | Nutrition and Blood | No data available |
|
YPV Vitamin D3 800unit tablets
0906040G0EHAECS
|
YPV Vitamin D3 | Colecalciferol | Nutrition and Blood | No data available |
|
Zarzio 48million units/0.5ml inj pre-filled syringes
0901060I0BFABAM
|
Zarzio | Filgrastim | Nutrition and Blood | No data available |
|
Zavesca 100mg capsules
0908010ACBBAAAA
|
Zavesca | Miglustat | Nutrition and Blood | No data available |
|
Zemplar 10micrograms/2ml solution for injection ampoules
0906040P0BBABAB
|
Zemplar | Paricalcitol | Nutrition and Blood | No data available |
|
Zemplar 2microgram capsules
0906040P0BBADAD
|
Zemplar | Paricalcitol | Nutrition and Blood | No data available |
|
Zemplar 4microgram capsules
0906040P0BBAEAE
|
Zemplar | Paricalcitol | Nutrition and Blood | No data available |
|
Zemplar 5micrograms/1ml solution for injection ampoules
0906040P0BBAAAA
|
Zemplar | Paricalcitol | Nutrition and Blood | No data available |
|
Zemplar 5micrograms/1ml solution for injection vials
0906040P0BBAFAF
|
Zemplar | Paricalcitol | Nutrition and Blood | No data available |
|
Zenalb 20% solution for infusion 100ml bottles
0902022A0BBABAC
|
Zenalb | Albumin solution | Nutrition and Blood | No data available |
|
Zenalb 20% solution for infusion 50ml bottles
0902022A0BBAAAB
|
Zenalb | Albumin solution | Nutrition and Blood | No data available |
|
Zenalb 4.5% solution for infusion 100ml bottles
0902022A0BBAFAE
|
Zenalb | Albumin solution | Nutrition and Blood | No data available |
|
Zenalb 4.5% solution for infusion 250ml bottles
0902022A0BBACAF
|
Zenalb | Albumin solution | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.